ID   B78/TNF
AC   CVCL_0160
DR   MCCL; MCC:0000052
DR   Wikidata; Q54752835
RX   PubMed=11228537;
CC   Genetic integration: Method=Transfection/transduction; Gene=HGNC; HGNC:11892; TNF.
CC   Derived from site: In situ; Skin; UBERON=UBERON_0002097.
CC   Breed/subspecies: C57BL/6.
DI   NCIt; C21790; Mouse melanoma
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_8341 ! B78H1
SX   Male
AG   Age unspecified
CA   Cancer cell line
DT   Created: 04-04-12; Last updated: 14-08-25; Version: 12
//
RX   PubMed=11228537; DOI=10.1038/sj.cgt.7700263;
RA   Lasek, Witold
RA   Mackiewicz, Andrzej
RA   Czajka, Anna
RA   Switaj, Tomasz
RA   Golab, Jakub
RA   Wiznerowicz, Maciej
RA   Korczak-Kowalska, Grazyna
RA   Bakowiec-Iskra, Ewa Z.
RA   Gryska, Katarzyna
RA   Izycki, Dariusz
RA   Jakobisiak, Marek
RT   "Antitumor effects of the combination therapy with TNF-alpha
RT   gene-modified tumor cells and interleukin 12 in a melanoma model in
RT   mice.";
RL   Cancer Gene Ther. 7:1581-1590(2000).
//